Skip to main content
Caplight Logo









Proton Health

Proton Health

Private
LondonHealthcare & Life Scienceshttps://www.proton-health.com/

Last Round

Accelerator

Sep 9, 2024

Total Funding Raised

$236,000

Company Overview

Proton Health is a healthcare technology company that develops an AI-powered platform called Symphony, designed to provide personalized skin health management and clinical support for dermatologists and patients.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

digital healtheczema managementmedical AItelemedicinepatient engagementskincare appsymptom trackingbehavioral therapyclinical workflowdermatology softwarehealth techSaaSfemtechD2CmHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proton Health Comparables

Compare Proton Health with similar companies based on industry and business-model similarity.

Proton Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Skinive
74%
Miiskin
63%
Teladoc Health, Inc.
63%

Proton Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 9, 2024
GrantMay 5, 2023
GrantNov 1, 2022

Key People

Founding team and executive leadership

Niall Jawad

CTO And Co-Founder

Founding Team

Haroon Ahmad

Co-Founder And CEO

Founding Team

Proton Health Investors

Notable investors and investment history

Proton Health investors
InvestorRounds
TechstarsAccelerator
Innovate UKGrant
National Institute for Health and Care ResearchGrant
UNT Health Science CenterAccelerator
Goff CapitalAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 76% MoM.

  • Jun 2, 2025

    Added Ucb Group, a pharmaceuticals company, as a customer.

Proton Health Filings

Explore SEC and related filing metadata, where available.

Proton Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Proton Health's valuation, stock price, and market status.

Is Proton Health a public or private company?

Proton Health is a private company.

What is the current stock price of Proton Health?

Proton Health is a private company with no public stock price. No recent secondary market data is available.

How much is Proton Health worth (valuation)?

Valuation information for Proton Health is not publicly available.

Can I buy Proton Health stock?

Proton Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Proton Health's last funding round?

Proton Health's most recent funding round was Accelerator on September 13, 2024.

Who are the main investors in Proton Health?

Key investors in Proton Health include Techstars, Innovate UK.

Will Proton Health IPO soon?

No public IPO plans have been announced for Proton Health.

How can I track Proton Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proton Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range2
Year Founded2020
Last FundingSep 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?